GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Asiri Surgical Hospital PLC (COL:AMSL.N0000) » Definitions » YoY EBITDA Growth

Asiri Surgical Hospital (COL:AMSL.N0000) YoY EBITDA Growth : -29.20% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Asiri Surgical Hospital YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Asiri Surgical Hospital's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -29.20%.

Asiri Surgical Hospital's EBITDA per Share for the three months ended in Dec. 2023 was රු1.02.


Asiri Surgical Hospital YoY EBITDA Growth Historical Data

The historical data trend for Asiri Surgical Hospital's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asiri Surgical Hospital YoY EBITDA Growth Chart

Asiri Surgical Hospital Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.33 11.89 26.76 60.20 26.25

Asiri Surgical Hospital Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.77 38.08 45.01 -1.05 -29.20

Asiri Surgical Hospital YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Asiri Surgical Hospital's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY EBITDA Growth (A: Mar. 2023 )
=(EBITDA per Share (A: Mar. 2023 )-EBITDA per Share (A: Mar. 2022 ))/ | EBITDA per Share (A: Mar. 2022 ) |
=(4.848-3.84)/ | 3.84 |
=26.25 %

Asiri Surgical Hospital's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(1.023-1.445)/ | 1.445 |
=-29.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asiri Surgical Hospital YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Asiri Surgical Hospital's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Asiri Surgical Hospital (COL:AMSL.N0000) Business Description

Traded in Other Exchanges
N/A
Address
No. 21, Kirimandala Mawatha, Colombo, LKA, 05
Asiri Surgical Hospital PLC is engaged in operating a two-tier hospital and provides healthcare services. The business of the company operates in segments that include Pre-care, Post-care, and Pharmaceutical segment. The pre-care includes OPD revenue, channeling revenue, and OPD lab investigation services, post-care which includes all IPD revenue including inpatient drugs and lab investigation, and pharmaceutical which includes OPD pharmacy revenue. Geographically the company provides its services to the Sri Lankan market.

Asiri Surgical Hospital (COL:AMSL.N0000) Headlines

No Headlines